← Back to HURA

TuHURA Biosciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 14/08/2026Mar 2026Filed 14/08/2026Sep 2025Filed 14/11/2025Jun 2025Filed 14/08/2026Mar 2025Filed 14/08/2026Sep 2024Filed 14/11/2025Jun 2024Filed 14/11/2025Mar 2024Filed 14/11/2025
$0$0$0
−$9.2−$7.5−$7.1−$9.5−$6.7−$5.6−$5.3−$4.8
−$0.14−$0.13−$0.14−$0.21−$0.15−$0.54−$0.43−$0.40
6460514543

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.